Bioequivalence study of Valsartan 160 mg
Not Applicable
- Conditions
- Healthy volunteers.
- Registration Number
- IRCT20200623047902N5
- Lead Sponsor
- Sanamed pharma company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
General Health (Liver, Heart and Kidney)
Body Mass Index (18-28)
Informed consent
Age (18-60 years old)
Exclusion Criteria
Smoking
History of cardiovascular disease
History of liver and kidney disease
Pregnancy
Alcoholism and Narcoticism
History of allergy to Valsartan
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Drug plasma concentration. Timepoint: Hour. Method of measurement: blood sampling.
- Secondary Outcome Measures
Name Time Method Pharmacokinetic parameters. Timepoint: After intervention. Method of measurement: Theoretical and pahrmacokinetic equations.